Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 4 Grant or award SVP, Chief Marketing Officer acquired 125,000 shares (grant or award)
  2. 4 Grant or award SVP, Business Development acquired 125,000 shares (grant or award)
  3. 4 Grant or award SVP & General Counsel acquired 125,000 shares (grant or award)
  4. 4 Grant or award SVP, CFO & Treasurer acquired 125,000 shares (grant or award)
  5. 4 Grant or award President and CEO acquired 525,000 shares (grant or award)
  6. 4 Open-market buy President and CEO bought 10,000 shares at $4.15 ($41,500)
  7. 4 Open-market sale Director sold 7,000 shares at $4.59 ($32,130)
  8. 4 Grant or award Director acquired 59,225 shares (grant or award)
  9. 4 Grant or award Director acquired 59,225 shares (grant or award)
  10. 4 Grant or award Director acquired 59,225 shares (grant or award)
  11. 4 Grant or award Director acquired 59,225 shares (grant or award)
  12. 4 Grant or award Director acquired 59,225 shares (grant or award)
  13. 4 Open-market buy President and CEO bought 10,000 shares at an average $4.40 ($43,995)
  14. 4 Open-market buy President and CEO bought 20,000 shares at $4.22 ($84,472)
  15. 4 Open-market buy President and CEO bought 10,000 shares at an average $5.02 ($50,150)
  16. 4 Open-market buy President and CEO bought 10,000 shares at an average $5.02 ($50,200)
  17. 4 Shares withheld for taxes SVP, Chief Marketing Officer gave up 15,520 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP, Business Development gave up 26,941 shares (to pay taxes)
  19. 4 Open-market buy President and CEO bought 10,000 shares at $4.71 ($47,050)
  20. 4 Shares withheld for taxes SVP, CFO & Treasurer gave up 26,941 shares (to pay taxes)

Page 2 of 29 · 579 filings